Bayer Recalls 1-Million Plus Cartons of Alka-Seltzer
Bayer Healthcare Pharmaceuticals has issued a voluntary Class II recall of more than one million (1,067,520) 12-count cartons of its over-the-counter product, Alka-Seltzer Original (325-mg aspirin, 1916-mg analgesic, sodium bicarbonate/antacid, 1000-mg anhydrous citric acid) effervescent tablets.
The recall was due to defective containers based on a confirmed customer compliant of small holes or cracks in the foil of blister packs.
A Class II recall is a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
The recall was initiated in the US on March 30, 2017 and posted on the US Food and Drug Administration website on August 1, 2017.
Source: US Food and Drug Administration